Cranial irradiation in childhood mimicking neurofibromatosis type II

被引:1
|
作者
Bokstein, Felix [1 ,2 ,3 ]
Dubov, Tom [3 ]
Toledano-Alhadef, Hagit [1 ,3 ]
Bernstein-Molho, Rinat [2 ,3 ]
Constantini, Shlomi [1 ,3 ,4 ]
Evans, D. Gareth [5 ]
Ben-Shachar, Shay [1 ,3 ]
机构
[1] Tel Aviv Med Ctr & Sch Med, Gilbert Israeli Neurofibromatosis Ctr, 6 Weizmann St, IL-6423906 Tel Aviv, Israel
[2] Tel Aviv Med Ctr & Sch Med, Dept Oncol, Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[4] Tel Aviv Med Ctr & Sch Med, Dept Pediat Neurosurg, Tel Aviv, Israel
[5] Univ Manchester, Manchester Royal Infirm, Inst Human Dev,Manchester Acad Hlth Sci Ctr, Ctr Manchester NHS Fdn Trust,Genom Med, Manchester, Lancs, England
关键词
neurofibromatosis type II; NF2; radiation; tinea capitis; vestibular schwannoma; TUMOR-PRONE SYNDROMES; IONIZING-RADIATION; SOMATIC MOSAICISM; EXPOSURE; DISEASE; RISK; MENINGIOMAS; SCHWANNOMAS; PREVALENCE; CANCER;
D O I
10.1002/ajmg.a.38211
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Neurofibromatosis type II (NF2) is a genetic disease characterized by bilateral vestibular schwannomas (VS) and other nerve system tumors. However, such tumors may be associated with environmental, rather than a genetic, etiology. Individuals fulfilling the clinical criteria of NF2 who had been treated by head ionized irradiation at a young age were compared for disease characteristics and molecular analysis with non-irradiated sporadic NF2 cases. In the study cohort, three of 33 sporadic adult cases fulfilling NF2 diagnostic criteria had a history of early age cranial irradiation exposure. None of the irradiated patients had bilateral VS compared with 73.3% of the non-irradiated individuals. One of the irradiated patients had no VS, while none of the non-irradiated NF2 cases had absence of VS. All of the irradiated individuals had brain meningiomas and thyroid tumors compared with 47% and 0%, respectively, of the non-irradiated individuals. Molecular analyses for NF2 mutations in blood of the irradiated individuals failed to detect disease-causing mutations. This study suggest that environmental factors may mimic NF2. Identifying such non-genetic cases fulfilling clinical criteria of the genetic disease may be crucial for the purposes of genetic counseling and patient management.
引用
收藏
页码:1635 / 1639
页数:5
相关论文
共 50 条
  • [31] Neurofibromatosis type II: An unusual presentation
    Burress, C.
    Savells, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 405 - 405
  • [32] Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]
    Evans, D. Gareth R.
    GENETICS IN MEDICINE, 2009, 11 (09) : 599 - 610
  • [33] Neuroimage of the Month Neurofibromatosis type II (Wishart type)
    Arya, Ravindra
    Sahu, Jitendra K.
    Kabra, Madhulika
    JOURNAL OF PEDIATRIC NEUROLOGY, 2009, 7 (03) : 333 - 335
  • [34] CRANIAL IRRADIATION IN CHILDHOOD LYMPHOBLASTIC-LEUKEMIA - TIME FOR REAPPRAISAL
    CHESSELLS, JM
    BRITISH MEDICAL JOURNAL, 1985, 291 (6497): : 686 - 687
  • [35] Treatment of Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
    Pui, C. H.
    Campana, D.
    Sandlund, J. T.
    Bhojwani, Deepa
    Evans, W. E.
    Relling, M. V.
    Jeha, S.
    ANNALS OF HEMATOLOGY, 2011, 90 : S61 - S63
  • [36] OSTEOPOROSIS AFTER CRANIAL IRRADIATION FOR CHILDHOOD LYMPHOBLASTIC-LEUKEMIA
    GILSANZ, V
    ORTEGA, J
    GIBBENS, DT
    CARLSON, ME
    PEDIATRIC RESEARCH, 1989, 25 (04) : A150 - A150
  • [37] Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
    Pui, Ching-Hon
    Campana, Dario
    Pei, Deqing
    Bowman, W. Paul
    Sandlund, John T.
    Kaste, Sue C.
    Ribeiro, Raul C.
    Rubnitz, Jeffrey E.
    Raimondi, Susana C.
    Onciu, Mihaela
    Coustan-Smith, Elaine
    Kun, Larry E.
    Jeha, Sima
    Cheng, Cheng
    Howard, Scott C.
    Simmons, Vickey
    Bayles, Amy
    Metzger, Monika L.
    Boyett, James M.
    Leung, Wing
    Handgretinger, Rupert
    Downing, James R.
    Evans, William E.
    Relling, Mary V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (26): : 2730 - 2741
  • [38] Hearing Preservation With the Middle Cranial Fossa Approach for Neurofibromatosis Type 2
    Friedman, Rick A.
    Goddard, John C.
    Wilkinson, Eric P.
    Schwartz, Marc S.
    Slattery, William H., III
    Fayad, Jose N.
    Brackmann, Derald E.
    OTOLOGY & NEUROTOLOGY, 2011, 32 (09) : 1530 - 1537
  • [39] NEUROFIBROMATOSIS TYPE-1 AND CHILDHOOD-CANCER
    MATSUI, I
    TANIMURA, M
    KOBAYASHI, N
    SAWADA, T
    NAGAHARA, N
    AKATSUKA, J
    CANCER, 1993, 72 (09) : 2746 - 2754
  • [40] Glioblastoma Multiforme in the Posterior Cranial Fossa in a Patient with Neurofibromatosis Type I
    Broekman, Marike L. D.
    Risselada, Roelof
    Engelen-Lee, JooYeon
    Spliet, Wim G. M.
    Verweij, Bon H.
    CASE REPORTS IN MEDICINE, 2009, 2009